• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    5T4 as a target for immunotherapy in renal cell carcinoma.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Elkord, Eyad
    Shablak, Alaaeldin
    Stern, Peter L
    Hawkins, Robert E
    Issue Date
    2009-12
    
    Metadata
    Show full item record
    Citation
    5T4 as a target for immunotherapy in renal cell carcinoma. 2009, 9 (12):1705-9 Expert Rev Anticancer Ther
    Journal
    Expert Review of Anticancer Therapy
    URI
    http://hdl.handle.net/10541/109310
    DOI
    10.1586/era.09.152
    PubMed ID
    19954280
    Type
    Article
    Language
    en
    ISSN
    1744-8328
    ae974a485f413a2113503eed53cd6c53
    10.1586/era.09.152
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research
    Medical Oncology

    entitlement

    Related articles

    • Immunotherapeutic approaches for renal cancer.
    • Authors: Pizza G, de Vinci C, Viza D
    • Issue date: 2002
    • Current immunotherapeutic strategies in renal cell carcinoma.
    • Authors: Amato RJ
    • Issue date: 2007 Oct
    • Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
    • Authors: Acres B
    • Issue date: 2007 Sep
    • Immunotherapy for renal cell cancer.
    • Authors: Yang JC, Childs R
    • Issue date: 2006 Dec 10
    • Vaccination of renal cell cancer patients with modified vaccinia ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: a phase II trial.
    • Authors: Amato RJ, Shingler W, Naylor S, Jac J, Willis J, Saxena S, Hernandez-McClain J, Harrop R
    • Issue date: 2008 Nov 15
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.